Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and MoreMay 10th 2024
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.